Federal (United States) · Regulations
Subpart H
35 sections
35 sections
- 21 C.F.R. § 864.7010Flow cytometric test system for hematopoietic neoplasms.
- 21 C.F.R. § 864.7040Adenosine triphosphate release assay.
- 21 C.F.R. § 864.7060Antithrombin III assay.
- 21 C.F.R. § 864.7100Red blood cell enzyme assay.
- 21 C.F.R. § 864.7140Activated whole blood clotting time tests.
- 21 C.F.R. § 864.7250Erythropoietin assay.
- 21 C.F.R. § 864.7275Euglobulin lysis time tests.
- 21 C.F.R. § 864.7280Factor V Leiden DNA mutation detection systems.
- 21 C.F.R. § 864.7290Factor deficiency test.
- 21 C.F.R. § 864.7293Von Willebrand factor assay.
- 21 C.F.R. § 864.7295Heparin and direct oral factor Xa inhibitor drug test system.
- 21 C.F.R. § 864.7300Fibrin monomer paracoagulation test.
- 21 C.F.R. § 864.7320Fibrinogen/fibrin degradation products assay.
- 21 C.F.R. § 864.7340Fibrinogen determination system.
- 21 C.F.R. § 864.7360Erythrocytic glucose-6-phosphate dehydrogenase assay.
- 21 C.F.R. § 864.7375Glutathione reductase assay.
- 21 C.F.R. § 864.7400Hemoglobin A 2 assay.
- 21 C.F.R. § 864.7415Abnormal hemoglobin assay.
- 21 C.F.R. § 864.7425Carboxyhemoglobin assay.
- 21 C.F.R. § 864.7440Electrophoretic hemoglobin analysis system.
- 21 C.F.R. § 864.7455Fetal hemoglobin assay.
- 21 C.F.R. § 864.7470Glycosylated hemoglobin assay.
- 21 C.F.R. § 864.7490Sulfhemoglobin assay.
- 21 C.F.R. § 864.7500Whole blood hemoglobin assays.
- 21 C.F.R. § 864.7525Heparin assay.
- 21 C.F.R. § 864.7660Leukocyte alkaline phosphatase test.
- 21 C.F.R. § 864.7675Leukocyte peroxidase test.
- 21 C.F.R. § 864.7695Platelet factor 4 radioimmunoassay.
- 21 C.F.R. § 864.7720Prothrombin consumption test.
- 21 C.F.R. § 864.7735Prothrombin-proconvertin test and thrombotest.
- 21 C.F.R. § 864.7750Prothrombin time test.
- 21 C.F.R. § 864.7825Sickle cell test.
- 21 C.F.R. § 864.7875Thrombin time test.
- 21 C.F.R. § 864.7900Thromboplastin generation test.
- 21 C.F.R. § 864.7925Partial thromboplastin time tests.